KLEMA CATHY has filed 5 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 9868 shares of OptimizeRx Corp ($OPRX) on June 11, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 11, 2025 | OptimizeRx Corp | $OPRX | KLEMA CATHY | Director | A | Common Stock | 9868 | $0.00 | 21,620.0000 | 20,234,186 | 83.97% | 0.05% |
| Feb. 2, 2025 | OptimizeRx Corp | $OPRX | KLEMA CATHY | Director | M | Common Stock | 5109 | $0.00 | 11,752.0000 | 20,194,697 | 76.91% | 0.03% |
| Feb. 2, 2025 | OptimizeRx Corp | $OPRX | KLEMA CATHY | Director | M | Restricted Stock Units | 5109 | $0.00 | 0.0000 | 20,194,697 | 100.00% | 0.03% |
| June 7, 2024 | OptimizeRx Corp | $OPRX | KLEMA CATHY | Director | A | Common Stock | 6643 | $0.00 | 6,643.0000 | 19,921,879 | 9999.99% | 0.03% |
| Feb. 2, 2024 | OptimizeRx Corp | $OPRX | KLEMA CATHY | Director | A | Restricted Stock Units | 5109 | $0.00 | 5,109.0000 | 19,899,679 | 9999.99% | 0.03% |